Cytokine effects on the basal ganglia and dopamine function: The subcortical source of inflammatory malaise

被引:274
作者
Felger, Jennifer C.
Miller, Andrew H. [1 ]
机构
[1] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA
基金
美国国家卫生研究院;
关键词
Inflammatory cytokines; Interferon-alpha; Inflammation; Dopamine; Tetrahydrobiopterin; Kynurenine; Oxidative stress; Basal ganglia; Fatigue; Depression; BLOOD-BRAIN-BARRIER; CENTRAL-NERVOUS-SYSTEM; TUMOR-NECROSIS-FACTOR; MAJOR DEPRESSIVE DISORDER; POSITRON-EMISSION-TOMOGRAPHY; SYNAPTOSOMAL GLUTAMATE RELEASE; RANDOMIZED CLINICAL-TRIAL; INDUCED SICKNESS BEHAVIOR; ACTIVATED PROTEIN-KINASE; INTERFERON-ALPHA THERAPY;
D O I
10.1016/j.yfrne.2012.09.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Data suggest that cytokines released during the inflammatory response target subcortical structures including the basal ganglia as well as dopamine function to acutely induce behavioral changes that support fighting infection and wound healing. However, chronic inflammation and exposure to inflammatory cytokines appears to lead to persisting alterations in the basal ganglia and dopamine function reflected by anhedonia, fatigue, and psychomotor slowing. Moreover, reduced neural responses to hedonic reward, decreased dopamine metabolites in the cerebrospinal fluid and increased presynaptic dopamine uptake and decreased turnover have been described. This multiplicity of changes in the basal ganglia and dopamine function suggest fundamental effects of inflammatory cytokines on dopamine synthesis, packaging, release and/or reuptake, which may sabotage and circumvent the efficacy of current treatment approaches. Thus, examination of the mechanisms by which cytokines alter the basal ganglia and dopamine function will yield novel insights into the treatment of cytokine-induced behavioral changes and inflammatory malaise. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:315 / 327
页数:13
相关论文
共 229 条
[71]   Abnormal Striatal Dopaminergic Synapses in National NeuroAIDS Tissue Consortium Subjects with HIV Encephalitis [J].
Gelman, Benjamin B. ;
Spencer, Jeffrey A. ;
Holzer, Charles E., III ;
Soukup, Vicki M. .
JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2006, 1 (04) :410-420
[72]   Is low folate a risk factor for depression? A meta-analysis and exploration of heterogeneity [J].
Gilbody, Simon ;
Lightfoot, Tracy ;
Sheldon, Trevor .
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2007, 61 (07) :631-637
[73]   Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: A HuGE review [J].
Gilbody, Simon ;
Lewis, Sarah ;
Lightfoot, Tracy .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2007, 165 (01) :1-13
[74]  
Ginsberg Lawrence D, 2011, Innov Clin Neurosci, V8, P19
[75]   ENHANCEMENT OF RECOVERY FROM PSYCHIATRIC-ILLNESS BY METHYLFOLATE [J].
GODFREY, PSA ;
TOONE, BK ;
CARNEY, MWP ;
FLYNN, TG ;
BOTTIGLIERI, T ;
LAUNDY, M ;
CHANARIN, I ;
REYNOLDS, EH .
LANCET, 1990, 336 (8712) :392-395
[76]  
Grace AA., 2002, Neuropsychopharmacology: The Fifth Generation of Progress, V1st, P119
[77]   Neuropathology of early HIV-1 infection [J].
Gray, F ;
Scaravilli, F ;
Everall, I ;
Chretien, F ;
An, S ;
Boche, D ;
AdleBiassette, H ;
Wingertsmann, L ;
Durigon, M ;
Hurtrel, B ;
Chiodi, F ;
Bell, J ;
Lantos, P .
BRAIN PATHOLOGY, 1996, 6 (01) :1-12
[78]  
Guidetti P, 2003, ADV EXP MED BIOL, V527, P137
[79]   Quinolinic acid selectively induces apoptosis of human astrocytes: potential role in AIDS dementia complex [J].
Guillemin, Gilles J. ;
Wang, Lily ;
Brew, Bruce J. .
JOURNAL OF NEUROINFLAMMATION, 2005, 2 (1)
[80]   Indoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer's disease hippocampus [J].
Guillemin, GJ ;
Brew, BJ ;
Noonan, CE ;
Takikawa, O ;
Cullen, KM .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2005, 31 (04) :395-404